Related Experiment Videos
Breast milk jaundice in premature infants
Insights
Preterm infants fed breast milk experienced higher bilirubin levels and prolonged jaundice compared to those on formula. This suggests breast milk may increase the need for clinical intervention in preterm infants.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Hyperbilirubinemia is a common concern in preterm infants.
- The role of diet in neonatal jaundice requires further investigation.
- Previous studies suggest potential links between breast milk and jaundice.
Purpose of the Study:
- To compare the incidence and severity of jaundice in preterm infants fed breast milk versus artificial preterm formula.
- To investigate the impact of diet on bilirubin levels and the need for clinical intervention.
- To explore the association between hyperbilirubinemia and neurodevelopmental outcomes.
Main Methods:
- A randomized study involving 186 preterm infants.
- Comparison of infants fed maternal/banked breast milk versus artificial preterm formula.
- Analysis of peak bilirubin concentration, jaundice duration, and plasma bilirubin values.
Main Results:
- Infants fed breast milk had significantly higher peak bilirubin concentrations and more prolonged jaundice.
- Breast milk-fed infants were over four times more likely to exceed 200 mumol/l bilirubin.
- This dietary effect persisted even in sick, ventilated preterm infants with restricted enteral intake.
Conclusions:
- Breast milk feeding in preterm infants may be associated with an increased risk of clinical intervention for jaundice.
- Findings warrant consideration of dietary management in preventing severe hyperbilirubinemia.
- Further research is needed to understand the mechanisms and long-term implications of breast milk jaundice in preterm infants.
Abstract:
In randomised study of 186 preterm infants those fed on maternal or banked breast milk had a significantly higher peak bilirubin concentration and a more prolonged jaundice than infants fed an artificial preterm formula and were over four times more likely to achieve plasma bilirubin values above 200 mumol/l (11.7 mg/100 ml). This dietary effect was seen even in a high risk subgroup of sick ventilated infants below 1500 g who were receiving restricted enteral intakes. We suggest that breast milk jaundice in preterm infants may increase clinical intervention. Our findings are discussed in the light of epidemiological data suggesting an association between moderate hyperbilirubinaemia (greater than 170 mumol/l) and neurodevelopmental outcome.